<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04709627</url>
  </required_header>
  <id_info>
    <org_study_id>100-P0093</org_study_id>
    <secondary_id>30000000064)</secondary_id>
    <nct_id>NCT04709627</nct_id>
  </id_info>
  <brief_title>enFlow IV Fluid and Blood Warming System</brief_title>
  <official_title>Verification of Clinical Utility: enFlow IV Fluid and Blood Warming System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vyaire Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vyaire Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is part of a post-market clinical follow-up (PMCF). The purpose of this study is&#xD;
      to verify in a routine clinical environment with a number of caregivers and subjects that the&#xD;
      enFlow performs as intended when used as an element of maintaining acceptable core&#xD;
      temperatures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible subjects from the study will be recruited from patients with scheduled surgeries.&#xD;
      After being informed about the study and potential risks, patients given informed consent&#xD;
      will undergo scheduled surgery with the use of enFlow IV Fluid and Blood Warming System. The&#xD;
      following temperature measurements will be collected during surgery:&#xD;
&#xD;
        -  Baseline temperature measurement (0-15 minutes prior to induction)&#xD;
&#xD;
        -  Induction temperature measurements (15 minutes, 30 minutes, 60 minutes, 90 minute&#xD;
           post-induction)&#xD;
&#xD;
        -  Continued temperature measurements (every 30 minutes, plus end of surgery)&#xD;
&#xD;
        -  OR ambient temperature at induction and end of surgery.&#xD;
&#xD;
      Temperature will be measured and collected post-surgery upon arrival to the PACU and 30&#xD;
      minutes post-arrival.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 6, 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Maintenance of intraoperative core temperature</measure>
    <time_frame>15 and 30 minutes post-induction, then every 30 minutes untl the termination of the scheduled surgical procedure, and a final measurement recorded at the time of termination of the scheduled surgical procedure.</time_frame>
    <description>Core temperature is defined as the highest tympanic temperature reading during 30 seconds made within 5 minutes of protocol time. The primary outcome measure will be the mean of the tympanic measurements taken during the course of surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Core temperature for two periods</measure>
    <time_frame>Induction: first 90 minutes. Post-Induction: after 90 minutes until the end of surgery,</time_frame>
    <description>The mean of the tympanic measurements taken during the Induction period and during the Post-Induction period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hypothermic events</measure>
    <time_frame>During 30 seconds made within 5 minutes of protocol time</time_frame>
    <description>The incidence and duration of hypothermic events (&lt;36.0C).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hyperthermic events</measure>
    <time_frame>During 30 seconds made within 5 minutes of protocol time</time_frame>
    <description>The incidence and duration of hyperthermic events (&gt;38.0 oC).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of infusate outside acceptable operating range (i.e., device &quot;green range&quot;)</measure>
    <time_frame>Induction: first 90 minutes. Post-Induction: after 90 minutes until the end of surgery,</time_frame>
    <description>Device reading 35-42 oC</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypothermia; Anesthesia</condition>
  <arm_group>
    <arm_group_label>60 minute surgery</arm_group_label>
    <description>Patients completing at least 60 minutes of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>enFlow IV Fluid and Blood Warming System</intervention_name>
    <description>The enFlow IV fluid/blood warming system's intended use is for warming blood, blood products and intravenous solutions prior to administration.</description>
    <arm_group_label>60 minute surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects from the study will be recruited from patients with scheduled surgeries. Most are&#xD;
        expected to be inpatient due to the exclusion of short surgeries. For this study, only&#xD;
        adults will be enrolled. Participation will also be limited to patients fluent in the&#xD;
        language(s) of the information and consent form.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Patients requiring surgery expected to last at least 1 hour.&#xD;
&#xD;
          -  Expectation of the perioperative need for at least one liter of infused fluids warmed&#xD;
             during infusion&#xD;
&#xD;
          -  Informed Consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Recent history of fever (&gt;38 C, within 24 hours of surgery)&#xD;
&#xD;
          -  Active infection&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Terminal illness (&lt;30 days)&#xD;
&#xD;
          -  Intended use of cardiopulmonary bypass&#xD;
&#xD;
          -  Clinical intention for perioperative cooling and hypothermia&#xD;
&#xD;
          -  unavailability of esophageal measurement during surgery&#xD;
&#xD;
          -  Attending physician does not believe participation of the patient is in their best&#xD;
             interest.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mikko Lax, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki and Uusimaa Hospital District, Helsinki University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seppo Mustola, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>South Karelia Central Hospital (EKSOTE, ALTEK), Dept. of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mikko Lax, MD</last_name>
    <phone>+050 428 6157</phone>
    <email>mikko.lax@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seppo Mustola, MD, PhD</last_name>
    <phone>+044 791 5832</phone>
    <email>seppo.mustola@eksote.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Helsinki and Uusimaa Hospital District, Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029 HUS</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Järvinen Jari, RN</last_name>
    </contact>
    <investigator>
      <last_name>Mikko Lax, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Karelia Central Hospital (EKSOTE, ALTEK)</name>
      <address>
        <city>Lappeenranta</city>
        <zip>53130</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jari Villanen, RN</last_name>
    </contact>
    <contact_backup>
      <last_name>Kimmo Repo, RN</last_name>
    </contact_backup>
    <investigator>
      <last_name>Seppo Mustola, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Campbell G, Alderson P, Smith AF, Warttig S. Warming of intravenous and irrigation fluids for preventing inadvertent perioperative hypothermia. Cochrane Database Syst Rev. 2015 Apr 13;(4):CD009891. doi: 10.1002/14651858.CD009891.pub2. Review.</citation>
    <PMID>25866139</PMID>
  </reference>
  <reference>
    <citation>National Institute of Health and Care Excellence (NICE). Hypothermia: prevention and management in adults having surgery Clinical guideline. Original Published: 23 April 2008. nice.org.uk/guidance/cg65 2019</citation>
  </reference>
  <reference>
    <citation>Pesonen E, Silvasti-Lundell M, Niemi TT, Kivisaari R, Hernesniemi J, Mäkinen MT. The focus of temperature monitoring with zero-heat-flux technology (3M Bair-Hugger): a clinical study with patients undergoing craniotomy. J Clin Monit Comput. 2019 Oct;33(5):917-923. doi: 10.1007/s10877-018-0227-z. Epub 2018 Nov 22.</citation>
    <PMID>30467673</PMID>
  </reference>
  <reference>
    <citation>Mäkinen MT, Pesonen A, Jousela I, Päivärinta J, Poikajärvi S, Albäck A, Salminen US, Pesonen E. Novel Zero-Heat-Flux Deep Body Temperature Measurement in Lower Extremity Vascular and Cardiac Surgery. J Cardiothorac Vasc Anesth. 2016 Aug;30(4):973-8. doi: 10.1053/j.jvca.2016.03.141. Epub 2016 Mar 22.</citation>
    <PMID>27521967</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 8, 2021</study_first_submitted>
  <study_first_submitted_qc>January 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothermia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

